ACADIA Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
ACADIA Pharmaceuticals has a total shareholder equity of $516.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $914.1M and $397.4M respectively. ACADIA Pharmaceuticals's EBIT is $22.8M making its interest coverage ratio -1.1. It has cash and short-term investments of $500.9M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -1.1x |
| Cash | US$500.94m |
| Equity | US$516.70m |
| Total liabilities | US$397.40m |
| Total assets | US$914.10m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0A4W's short term assets ($728.9M) exceed its short term liabilities ($337.9M).
Long Term Liabilities: 0A4W's short term assets ($728.9M) exceed its long term liabilities ($59.5M).
Debt to Equity History and Analysis
Debt Level: 0A4W is debt free.
Reducing Debt: 0A4W has not had any debt for past 5 years.
Debt Coverage: 0A4W has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 0A4W has no debt, therefore coverage of interest payments is not a concern.